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After the UNGA High-Level Meeting on Tuberculosis—
what next and how? 
Although tuberculosis is curable and preventable, it 
remains the leading infectious cause of death worldwide. 
The 2018 WHO Global Tuberculosis Report1 states that, 
in 2017, an estimated 10·0 million people globally 
(5·8 million men, 3·2 million women, and 1·0 million 
children) fell ill with tuberculosis, of whom 1·6 million 
died. Tuberculosis is also a major cause of morbidity 
and mortality in people living with HIV infection.1 
Multidrug-resistant tuberculosis is now a serious threat 
to global health security, adding to the growing burden 
of antimicrobial resistance. In 2017, of an estimated 
558 000 people with drug-resistant tuberculosis, only 
one in four received treatment, with treatment success 
rates estimated at 54% versus an optimal target of 90%.1 
Tuberculosis incidence is decreasing at a slow pace of 
1·5% each year. These annual rates of reduction need 
to rise to 4–5% by 2020 in order to meet the WHO End 
TB Strategy targets2 of a 90% reduction in the number 
of deaths due to tuberculosis, and an 80% reduction in 
tuberculosis incidence between 2016 and 2030.
To achieve these daunting targets, a major step-
change in political will was required to put global efforts 
to end tuberculosis back on course. On Sept 26, 2018, 
the first ever UN General Assembly (UNGA) High-Level 
Meeting on Tuberculosis (UNGA-HLM-TB), with more 
than 1000 participants from across the world, assembled 
in New York.3 The meeting resulted in the adoption of a 
Political Declaration on Tuberculosis3,4 on Oct 10, 2018, 
which reaffirmed commitment to end the tuberculosis 
epidemic globally by 2030 and included ambitious 
and bold targets for scale-up of tuberculosis care and 
prevention services, as well as commitments on research 
for new tools, principles of equity and human rights, and 
resource needs targets for both implementation and 
research. A follow-up WHO Executive Board meeting 
focused on ending tuberculosis re-affirmed targets set 
for 2022.5
An unprecedented level of political commitment to 
ending the tuberculosis pandemic was achieved at the 
UNGA-HLM-TB.6,7 Encouragingly, this has continued and 
remains strong, with some heads of states and most 
ministers of health personally involved, particularly 
those from countries that proactively participated in the 
process before and during the UNGA-HLM-TB. Now is 
the time to translate this political will and commitments 
into practical action within the short timeframe of 
the targets. The Declaration created unprecedented 
opportunities requiring concrete actions7 and raises the 
questions: what next and how?
Three critical components—funding, action, and 
ac countability—will be pivotal to the success of 
the initiatives of the UNGA High-Level meeting on 
Tuberculosis. First and foremost, is for UN member 
states to make available the resources needed. The 
UNGA Declaration calls for mobilisation of US$13 billion 
per year for implementation and an additional $2 billion 
per year for research into new tools.3,4 In 2017, less 
than $7 billion was available for implementation and 
about $0·7 billion was available for research.1,8 Thus, 
funding for tuberculosis implementation needs to 
almost double and for research it needs to almost 
triple. The Global Fund to Fight AIDS, Tuberculosis and 
Malaria, which is the main external funding source for 
tuberculosis globally, is going for its sixth replenishment 
in October, 2019. The tuberculosis aspect of the Global 
Fund Investment Case for replenishment is aligned 
with the Political Declaration on Tuberculosis and is for 
the critical period 2020–22, when most of the scale-up 
towards achieving the UNGA tuberculosis targets is 
anticipated to occur.9 Several high-tuberculosis-burden 
countries depend heavily on the Global Fund for their 
tuberculosis programmes and Global Fund grants 
have a catalytic and important role in various low-
income and middle-income countries. Although a fully 
replenished Global Fund will be important, national 
domestic budgets also need to increase significantly 
in all tuberculosis-endemic countries, and additional 
sources of funds through loans, bilateral aid, social 
health insurance, and innovative and impact financing 
will be required.10 For research funding, national 
governments need to commit resources and contribute 
their fair share based on income and capacity to do so.3,8 
Investing in tuberculosis is said to be one of the smartest 
investments among the Sustainable Development Goal 
(SDG) targets, with a return on investment of $43 per 
dollar spent.11
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Second, rapid action by countries, donors, and 
stakeholders is required for scaling up tuberculosis care 
and prevention as well as fast-tracking research into the 
development of new diagnostics, drugs, and vaccines. 
An estimated 4 million people are currently being left 
behind without being identified and receiving any 
quality tuberculosis care. These so-called missing people 
with tuberculosis need to be found and put on effective 
treatment for drug-susceptible and drug-resistant 
tuberculosis.12 Century-old diagnostic tools such as 
light microscopy for tuberculosis diagnosis need to be 
replaced or complemented with accurate and rapid point-
of-care molecular diagnostic tests. Shorter and more 
effective tuberculosis treatment regimens, including 
the all-oral drugs treatment regi men for multidrug-
resistant tuberculosis, need to replace previous regimens. 
The expanding pipeline of tools for diagnosis and 
treatment need increased funding and fast-tracking 
of development, evaluation, and implementation. 
Preventive therapy for latent tuberculosis infection 
needs to be scaled up for contacts (adults and children), 
people living with HIV, and other risk groups. To achieve 
this, national tuberculosis programmes will need to 
change their current mode of operating and mindset, 
modernising their tools and approaches, incorporating 
new information technology, and increasing their risk 
appetite to implement out-of-the box, practical, locally 
relevant solutions to address any operational problems.
Third, a specific independent monitoring and 
accountability mechanism was absent from the Political 
Declaration and is essential to hold world leaders, 
national governments, and stakeholders accountable 
to the commitments made. The global targets in the 
declaration are now categorised and delineated by 
individual country-level targets to ensure that progress 
by countries can be tracked.13 Encouragingly, several 
countries are in the process of breaking down national 
targets into provincial and state-level targets. The 
precise accountability mechanism is yet to be agreed 
upon. It needs to be multisectoral as well as multi-
stakeholder and inclusive. Civil society and affected 
communities need to be part of the accountability 
mechanism. Accountability should not stop at the level 
of health ministers but should be at the level of heads 
of state and governments. This is easier said than done 
and difficult to implement, but there are examples 
to follow, such as the Africa Leaders Malaria Alliance 
(ALMA) score card for heads of state.14 The Director-
General of WHO is expected to develop the multisectoral 
accountability framework in line with World Health 
Assembly resolution 71.3 and ensure its timely imple-
mentation no later than the end of 2019.3
On March 24, 2019, the world will observe the 
first World TB Day to be held after the High-Level 
Meeting on tuberculosis. The Stop TB Partnership, in 
consultation with Partners and stakeholders, has set the 
theme of World TB Day 2019 as “It’s Time...”. This theme 
has been deliberately kept flexible so that a wide range 
of views and messages from communities and the 
global tuberculosis fraternity can be expressed from all 
continents on World TB Day, to prompt concrete actions 
and deliverables from governments as committed 
through the Political Declaration.3 The declaration calls 
for a progress report in 2020 and a comprehensive 
review by heads of state and governments at a high-
level meeting in 2023. These will provide opportunities 
to hold world leaders accountable for contributing 
resources, progress, and successes and failures to meet 
targets. Close collaboration among all stakeholders, 
including governments of tuberculosis-endemic 
countries, specialised agencies of the UN, UN regional 
commissions, the Stop TB Partnership, WHO, UNITAID, 
the Global Fund, tuberculosis advocates, researchers, 
community leaders, patient groups, donors, and grant-
awarding bodies, will be essential to the implemen-
tation and achievement of the Political Declaration on 
Tuberculosis, and to ending the tuberculosis epidemic.
Suvanand Sahu, Lucica Ditiu, *Alimuddin Zumla
Stop TB Partnership Secretariat, Global Health Campus, Geneva, 
Switzerland (SS, LD); Division of Infection and Immunity, 
Center for Clinical Microbiology, University College London, 
London, UK (AZ); and National Institute of Health Research 
Biomedical Research Centre, University College London Hospitals 
NHS Foundation Trust, London, UK (AZ)
a.zumla@ucl.ac.uk
All authors are advocates for tuberculosis and members of the STOP TB 
Partnership. We declare no competing interests.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open 
Access article under the CC BY 4.0 license.
1 WHO. Global tuberculosis report 2018. Geneva: World Health Organization, 
2018.
2 WHO End TB strategy. Global strategy and targets for tuberculosis prevention, 
care and control after 2015. https://www.who.int/tb/post2015_strategy/en/ 
(accessed Feb 1, 2019).
3 UNGA. A/RES/73/3 (2018). Political declaration of the high-level meeting of 
the General Assembly on the fight against tuberculosis. http://www.un.org/
en/ga/search/view_doc.asp?symbol=A/RES/73/3 (accessed Feb 1, 2019).
Comment
www.thelancet.com/lancetgh   Vol 7   May 2019 e560
4 Stop TB Partnership. UNHLM on TB Key Targets for 2022. 2018. 
http://stoptb.org/assets/documents/global/advocacy/unhlm/UNHLM_
Targets&Commitments.pdf (accessed Feb 28, 2019).
5 WHO. Executive Board 144th session. Follow-up to the high-level meetings 
of the United Nations General assembly on health-related issues. 
Ending tuberculosis. Dec 13, 2018. http://www.stoptb.org/news/
stories/2018/ns18_072.asp (accessed Feb 12, 2019).
6 Zumla A, Petersen E. The historic and unprecedented United Nations 
General Assembly High Level Meeting on Tuberculosis (UNGA-HLM-TB)–
’United to End TB: An Urgent Global Response to a Global Epidemic’. 
Int J Infect Dis 2018; 75: 118–20.
7 Herbert N, Sharma V, Masham BS, Sheehan BS, Hauser J, Zumla A. 
Concrete action now: UN High-Level Meeting on Tuberculosis. 
Lancet Infect Dis 2018; 18: 709–10.
8 TAG-Stop TB Partnership. 2018. Tuberculosis research funding trends 
2005–2017. http://www.treatmentactiongroup.org/sites/default/files/tb_
funding_2018_final.pdf (accessed Feb 4, 2019).
9 The Global Fund. Investment case summary. Sixth replenishment 2019. 
https://www.theglobalfund.org/media/8174/publication_
sixthreplenishmentinvestmentcase_summary_en.pdf (accessed Feb 4, 2019).
10 STOP TB Partnership. Decision points. 31st board meeting, 
20–30 January 2019 Geneva, Switzerland. http://stoptb.org/assets/
documents/about/cb/meetings/31/31%20Outcomes/31%20Stop%20
TB%20Board%20Decision%20Points.pdf (accessed Feb 4, 2019).
11 Copenhagen Consensus Center. The Nobel Laureates’ guide to the 
smartest targets for the world 2016–2030. https://www.copenhagen 
consensus.com/sites/default/files/post2015brochure_m.pdf (accessed 
Feb 4, 2019).
12 Stop TB Partnership 2017. 90(90)90: the tuberculosis report for heads of 
states and governments. http://www.stoptb.org/assets/documents/
resources/publications/acsm/909090_PDF_LR.pdf (accessed 
Feb 2, 2019).
13 Stop TB Partnership. UN High Level Meeting on TB: key targets and 
commitments for 2022 and outlined in the UN declaration on TB. 
http://stoptb.org/global/advocacy/unhlm_targets.asp (accessed 
Feb 28, 2019).
14 African Leaders Malaria Alliance. The ALMA scorecard for accountability 
and action: documentation of experiences and progress. http://alma2030.
org/sites/default/files/initiatives/alma_scorecard_for_accountability_and_
action.pdf (accessed Feb 10, 2019).
